What is the recommended treatment regimen for syphilis, including management of early versus late disease, pregnancy, penicillin allergy, and possible neurologic involvement?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Syphilis Treatment Recommendations

Benzathine penicillin G remains the definitive treatment for all stages of syphilis: a single intramuscular dose of 2.4 million units for early syphilis (primary, secondary, and early latent <1 year), and three weekly doses of 2.4 million units for late latent syphilis, latent syphilis of unknown duration, and tertiary syphilis. 1

Treatment by Stage

Early Syphilis (Primary, Secondary, Early Latent <1 Year)

  • Single IM injection of benzathine penicillin G 2.4 million units 1
  • Treatment success rates: 90-100% 2
  • Serologic response should be evident by 6 months 2

Late Latent Syphilis or Unknown Duration

  • Benzathine penicillin G 2.4 million units IM weekly for 3 consecutive weeks (total 7.2 million units) 1
  • Serologic response is slower, typically requiring 12-24 months 2
  • If a dose is missed, an interval of 10-14 days between doses may be acceptable before restarting the sequence 1, 3
  • Critical caveat: Missed doses are NOT acceptable in pregnant patients—they must repeat the full course 1

Tertiary Syphilis (Gumma, Cardiovascular)

  • Same regimen as late latent: benzathine penicillin G 2.4 million units IM weekly × 3 doses 1
  • Perform CSF examination before therapy if symptomatic 1
  • Consider neurosyphilis regimen for cardiovascular syphilis in consultation with infectious disease specialist 1

Neurosyphilis

  • Requires penicillin regimens that achieve treponemicidal CSF levels 1
  • Standard approach: IV benzyl penicillin 12-24 million units daily for 10-14 days 4
  • Alternative: Procaine penicillin 2.4 million units IM daily plus probenecid 500 mg orally 4 times daily 4

Special Populations

Pregnancy

Benzathine penicillin G is the ONLY acceptable treatment during pregnancy 5, 6

  • Dose according to maternal stage of infection per standard guidelines 5
  • Screen 3 times: first prenatal visit, third trimester, and at delivery 7
  • For viable pregnancies, administer first dose in labor and delivery with continuous fetal monitoring for 24 hours due to risk of Jarisch-Herxheimer reaction (occurs in up to 44% of pregnant patients) 5
  • Subsequent doses can be given outpatient 5
  • Check titers monthly after treatment to detect four-fold increases indicating reinfection or treatment failure 5

Penicillin Allergy

For early latent syphilis in non-pregnant patients:

  • Doxycycline 100 mg orally twice daily for 14 days (same as primary/secondary) 1

For late latent or unknown duration in non-pregnant patients:

  • Doxycycline 100 mg orally twice daily for 28 days 1
  • Alternative: Tetracycline 500 mg orally 4 times daily for 28 days 1
  • Ceftriaxone may be effective but optimal dose/duration undefined—use only in consultation with specialist 1
  • Important: Some penicillin-allergic patients are also allergic to ceftriaxone 1

For pregnant patients with penicillin allergy:

  • Desensitization is mandatory, followed by penicillin treatment 5
  • No alternative antibiotics are acceptable during pregnancy 5, 6

HIV-Infected Patients

  • Use same penicillin regimens as HIV-negative patients 3
  • No added benefit to enhanced antimicrobial therapy 3
  • However, treatment failures and early neurosyphilis development have been reported 4
  • Consider more frequent serologic monitoring

Indications for CSF Examination

Perform lumbar puncture promptly if patient demonstrates:

  • Neurologic signs: auditory disease, cranial nerve dysfunction, meningitis, stroke, altered mental status, loss of vibration sense 1
  • Ophthalmic signs: iritis, uveitis 1
  • Evidence of active tertiary syphilis: aortitis, gumma 1
  • Serologic treatment failure 1
  • Titers increase fourfold after treatment 1
  • Initially high titer (≥1:32) fails to decline at least fourfold within 12-24 months 1

Follow-Up Monitoring

Quantitative nontreponemal tests (RPR/VDRL) at 6,12, and 24 months 1

Treatment Failure Criteria:

  • Fourfold increase in titers 1
  • High initial titer (≥1:32) fails to decline fourfold within 12-24 months 1
  • Development of signs/symptoms attributable to syphilis 1

If treatment failure occurs: Perform CSF examination and retreat for latent syphilis even if CSF is negative 1

Common Pitfalls

  1. Serofast state: Patients may remain seropositive with low titers (<1:8) despite adequate treatment 2, 5—this does not necessarily indicate treatment failure

  2. Pregnancy treatment gaps: Any missed dose in pregnant women requires restarting the entire course 1—this is non-negotiable

  3. Inadequate CSF penetration: Standard benzathine penicillin regimens do not achieve treponemicidal CSF levels 4—always use appropriate neurosyphilis regimens when CNS involvement is suspected

  4. Penicillin supply shortages: Ongoing global shortages threaten treatment availability 6—early identification and treatment planning is essential

  5. Overdiagnosis of penicillin allergy: Many patients labeled as penicillin-allergic are not truly allergic 6—consider allergy testing when feasible, especially in pregnancy

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.